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Introduction
Age related macular degeneration (AMD) is the leading 
cause of blindness in the elderly in developed countries 
(1,2). Due to the growing aging population and increased 
life expectancy, the number of AMD cases is expected 
to be doubled by 2020 (3). The early stage of AMD is 
characterized by the deposition of extracellular materials 
beneath (basal laminar and basal linear deposition and 
drusen) or above (pseudo-drusen) the retinal pigment 
epithelium (RPE). The disease can advance into two late 
stages, “dry” and “wet”. Dry AMD refers to the geographic 
atrophy of the macula; whereas wet AMD is the growth 
of abnormal blood vessels into the macula, also known as 
neovascular AMD (nAMD). Although nAMD is treated by 
intravitreal injection of vascular endothelial growth factor 
inhibitors (e.g., anti-VEGF antibodies), the treatment is 
not curative, and patients eventually lose their central vision 
due to the development of geographic atrophy or macular 
fibrosis (4). Dry AMD is more common than the wet form 
and there is currently no treatment for it. AMD remains to 
be a major medical and socioeconomic challenge worldwide. 
Therefore, there is an urgent need for better therapies 
or prevention, and further understanding the underlying 
mechanisms of the disease is essential to achieve this.
Macrophage dysfunction in AMD
Macrophage dysfunction plays an important role in the 
pathogenesis of AMD (5,6). Macrophages may contribute 
to the development of AMD at multiple levels. When 
the macula suffers from oxidative insults, microglia and 
macrophages may migrate to the subretinal space (7), 
the junction between photoreceptor and RPE cells 
(Figure 1), with the intention to clean debris and maintain 
homeostasis, a phenomenon known as para-inflammation 
(8,9). Choroidal macrophages may also infiltrate into the 
sub-RPE space (2,10) (Figure 1). Once they phagocytize 
debris, they are removed from the subretinal space and 
sub-RPE space, and impaired removal of these cells 
causes subretinal inflammation and photoreceptor 
degeneration (6). If subretinal phagocytes are unable to 
remove debris, particularly when the RPE function is 
compromised and waste materials cannot be digested or 
transported by RPE to the choroid, subretinal drusenoid 
deposits (also known as pseudo-drusen) may occur. 
Choroidal macrophages are important scavenger cells 
responsible for the removal of waste materials and debris 
from the Bruch’s membrane and choroidal parenchyma 
(Figure 1). Malfunction of choroidal macrophages may 
lead to the development of basal laminar deposits and 
drusen. Drusen consists of cholesterol-rich lipids and 
various oxidized proteins, which can induce inflammasome 
activation (11), and complement activation (12) leading to 
the death of RPE and photoreceptors, cardinal features of 
dry AMD.
In wet AMD, the development of macular blood vessels 
such as choroidal neovascular membrane (CNV) (Figure 1) 
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is driven by abnormal levels of VEGF, which is why 
intravitreal injection of VEGF inhibitors is effective in 
treating the disease. Although multiple types of cells in the 
macula may produce VEGF in wet AMD, macrophage-
driven inflammation is known to play a pivotal role (13). 
Infiltrating macrophages have been detected in human 
AMD (14). Myeloid cells from AMD patients express 
higher levels of phosphorylated STAT3 (15) and produce 
higher levels of VEGF, IL6 and are more proangiogenic 
when cultured in vitro (16). Macrophages can directly or 
indirectly participate in retinal angiogenesis in wet AMD. 
Macrophages, as an important type of innate immune cells, 
are supposed to clean debris and promote tissue repair when 
macula suffers from oxidative damage. Why macrophages 
become detrimental in AMD still remains elusive.
Lipid metabolism and AMD
Fatty acids such as cholesterol and triglycerides are 
important fuel  source of the retina.  In the outer 
layers of the retina, lipid-rich photoreceptor outer 
segments are regenerated daily to recycle the light-
sensitive visual pigments (e.g., retinal). Photoreceptors 
maintain the metabolic demands by taking up a large 
amount of fatty acids through free tatty acid receptor 
1 (Ffar1) and very-low-density lipoprotein receptor 
Figure 1 Cholesterol homeostasis and macrophage malfunction at the retina-choroidal interface in age-related macular degeneration. 
Photoreceptors acquire cholesterols and fatty acids from choroidal circulation or synthesize internally using acetyl-CoA to maintain the 
high-rate of photoreceptor outer segment (POS) turnover. The POS is phagocytized and digested by RPE cells. Retinal waste materials 
are dumped to choroid and then removed by choroidal macrophages. During aging, RPE function declines leading to the accumulation of 
undigested POS at the subretinal space or within RPE cells (in the form of lipofuscin). Macrophages and microglia migrate to subretinal 
space to remove undigested lipid-rich POS and damaged RPE debris. Macrophages may also migrate to sub-RPE space to remove debris. 
In AMD, macrophages are unable to maintain intracellular cholesterol/fatty acid homeostasis resulting in the accumulation of oxidized fatty 
acid (e.g., oxysterol). Intracellular oxysterol may activate various signalling pathways leading to macrophage malfunction. These include (I) 
reduced phagocytosis, which may be related to drusen formation; (II) uncontrolled inflammatory cytokine production, which may lead to 
RPE and photoreceptor death and the development of dry AMD; (III) the production of pro-angiogenic growth factors, which may induce 
wet AMD. ApoRPE, apoptotic RPE; BM, Bruch’s membrane; Cap, choriocapillaris; CNV, choroidal neovascularization; Dr, drusen; MФ, 
macrophages; RPE, retinal pigment epithelium. 
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(VLDLR) (17). The fatty acids are acquired exogenously 
from choroidal circulation, although they can also 
be generated endogenously through the glycolysis 
pathway i.e., acetyl coenzyme A (acetyl-CoA) (18). 
Dysregulated lipid metabolism is known to play an 
important role in the development of AMD although the 
underlying mechanism needs further investigation. 
Impaired glucose and fatty acid uptake in photoreceptors 
results in a reduction in the levels of the Krebs cycle 
intermediate α-ketoglutarate. Low levels of α-ketoglutarate 
stabilize hypoxia-induced factor 1α (HIF1α) and induces 
retinal angiogenesis including wet AMD (17). Although 
evidence supporting glucose and fatty acid deficiency in 
AMD barely exists, compelling evidence suggests that 
dysregulated cholesterol and lipid homeostasis plays a 
pivotal role in AMD (18). The polymorphisms of genes 
related to lipid/lipoprotein metabolism have been associated 
with AMD (18). Higher circulating levels of high-density 
lipoprotein-cholesterol (HDL-C) are associated with 
increased risk for AMD (19). HDL can remove cholesterol 
from cells and is considered to be protective [compared 
with low density lipoprotein (LDL)]. It is possible that 
the structure of cholesterol within the HDL in AMD 
patients may differ from that in healthy controls. Indeed, 
a recent study by Lin et al. has shown that plasma levels 
of oxidized cholesterols, the oxysterols, in particular the 
24-hydroxycholesterol can discriminate physiological aging 
from AMD (20). The study highlights the role of oxidized 
cholesterols in the development of AMD.  
Lipid metabolism dysregulation and macrophage 
malfunction in AMD
Although the pathogenic roles of macrophage malfunction 
and cholesterol/lipid metabolism dysregulation in AMD 
have been recognized for over a decade, little is known 
on how the two phenomena are linked. Macrophages 
are specialized in metabolizing lipid and this function is 
needed for them to eliminate cholesterol that they acquire 
through the phagocytosis of dying cells. On the other hand, 
macrophage activation and polarization are regulated by the 
metabolic pathways. For example, the classically activated 
M1 macrophages are fuelled by the glycolysis pathway, 
whereas the alternatively activated M2 macrophages relay 
on fatty acid oxidative phosphorylation (21). The study 
by Lin and colleagues (20) suggests that macrophage 
malfunction in AMD may be related to cholesterol 
metabolism dysregulation. First, the authors showed that 
mitochondrial oxidative phosphorylation is considerably 
impaired in aged macrophages. Using transcriptomic 
approaches, the authors discovered global impairments in 
cholesterol and lipid homeostasis, including cholesterol/
lipid biosynthesis, elimination, transport and uptake (20). 
Importantly, they found that the intracellular levels of 
oxidized cholesterol including 4β-hydroxycholesterol, 
7-ketocholesterol and cholestane-3β, 5α, 6β-triol were 
higher in aged macrophages, particularly after treatment 
with oxidized LDL (20). 
This observation is important as accumulation of 
intracellular cholesterol can lead to activation of several 
transcription factors, including the liver X receptor α 
and β (LXRα and LXRβ), the retinoid X receptor (RXR) 
and member of the peroxisome proliferator-activated 
receptor (PPAR) family including PPARα and PPARγ (22). 
Normally, the LXR and RXR would form heterodimers 
that can upregulate the expression of the ATP-binding 
cassette subfamily A member 1 (ABCA1) and ABCG1 (22), 
which can then regulate the efflux of free cholesterol in 
order to maintain cellular cholesterol homeostasis. This 
regulatory mechanism appears to be impaired in aged 
macrophages, particularly in AMD. The expression of 
ABCA1 and cholesterol efflux is known to be reduced in 
aged macrophages (23), and ABCA1 polymorphisms are 
associated with advanced AMD (24). Statins, which inhibits 
the 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) 
reductase and reduces cholesterol production from acetyl-
CoA, can reduce some high-risk features of AMD (25). 
Furthermore, activation of the PPARs is also shown to be 
involved in the development of AMD (26). Taken together, 
these results suggest that accumulation of intracellular 
oxysterols in macrophages may confer their pathogenic 
phenotype leading to the development of AMD. 
In the context of AMD, impaired macrophage scavenger 
function may be related to the development of drusen 
and pseudo-drusen, whereas uncontrolled macrophage 
activation towards pro-inflammatory or pro-angiogenic 
phenotype may lead to the development of dry or wet 
AMD (Figure 1). Further studies are required to understand 
why and how cholesterol metabolism is dysregulated and 
which signalling pathways and functions of macrophage are 
affected by intracellular oxysterols in AMD.
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